THE ROLE OF VITAMIN-D3 IN THE PROLIFERATION OF A HUMAN-COLON CANCER CELL-LINE INVITRO

Authors:
  • MWMJ WARGOVICH
    MJ WARGOVICH
  • SSS SAEZ
    S SAEZ
  • BLB LEVIN
    B LEVIN
  • DWDM WILDRICK
    DM WILDRICK
  • BBBM BOMAN
    BM BOMAN

  • 1 July 1987
    • journal article
    • research article
    • Vol. 7  (4) , 817-821
    • PMID:2823686
Abstract
LoVo, a cultured colon cancer cell line, is shown to possess a receptor for 1,25-dihydroxy vitamin D3 (1.alpha.,25(OH)2D3) with a low capacity (28 fmol/mg protein) and high affinity (Kd: 1.9 .times. 10-210 M). When these cells were grown in monolayer culture in a chemically defined serum-free medium, a significant inhibition of proliferation was seen in the presence of 10 nM to 1 .mu.M of 1.alpha.,25(OH)2D3 (p < 0.005). Furthermore, 1.alpha.,25(OH)2D3 delayed early attachment of cells. After 8 days of treatment, aggregated cuboidal cells showed a marked change to an apparently spindle like morphology. The 1.alpha.,25(OH)2D3 growth-inhibitory effect was modulated by verapamil (1 .mu.M), a calcium channel blocker, hydrocortisone (1 .mu.M), and moxestrol (1mM), an estrogen analogue, and 2% charcoal-treated fetal bovine serum. This study represents the first demonstration of 1.alpha.,25(OH)2D3 modulation of growth of human colon cells.